Home › Gilead Buys Shortcut For FDA Drug Review For $125 Million
 

Keywords :   


Gilead Buys Shortcut For FDA Drug Review For $125 Million

2014-11-20 19:13:00| Biotech - Topix.net

How much is a fast track for the Food and Drug Administration review of a new drug worth? Try $125 million. In an auction, Gilead Sciences, a maker of HIV and hepatitis medicines, just bought a coupon good for the accelerated review of a drug of the company's choice from Knight Therapeutics, a Canadian company.

Tags: review million drug buys

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
28.09Tropical Storm Joyce Forecast Advisory Number 5
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 11
More »